Ipca Laboratories Ltd.: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

Particulars	Mar-25	Jun-25	Sep-25	Dec-25	Mar-26
Revenue	2,247	2,309	2,556	2,392	2,388
Other income	26	33	28	20	94
Expenses	1,939	2,011	2,135	1,984	2,032
Cost of materials consumed	660	617	570	564	593
Purchases of stock-in-trade	87	127	127	130	149
Change in inventories	-39	-52	85	-36	-50
Employee benefit expense	501	543	538	546	533
Finance costs	22	19	20	18	20
Depreciation & amortisation	100	100	103	108	107
Other expenses	609	658	692	655	680
EBITDA	250	450	515	572	531
EBIT	150	350	412	464	424
Exceptional items	-205	-	-58	18	-46
Profit Before Tax	128	331	392	446	404
Tax expense	62	96	108	82	95
Deferred tax	-27	0.30	-0.40	-30	-7
Net Profit	64	233	281	364	307
Financial Ratios
Operating Profit Margin	6.65%	15.14%	16.10%	19.38%	17.76%
EBITDA Margin	11.10%	19.47%	20.13%	23.90%	22.24%
Net Profit Margin	2.85%	10.09%	10.99%	15.22%	12.86%
Earnings Per Share (₹)	2.67	9.19	11.14	12.86	11.79

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.